Business Wire

Avania Buys Spanish MedTech CRO Anagram to Enhance Its Core CRO Offering in a New European Geography

Share

Avania, the leading, global medical technology contract research organization (CRO) and advisory services partner, today announced its acquisition of Anagram. Headquartered in Barcelona, Spain, Anagram is one of the leading MedTech CROs in the Iberian Peninsula, providing MedTech solutions to its customers in Spain, the wider European market, and beyond.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241008530546/en/

Avania, the leading, global medical technology contract research organization and advisory services partner, announces its acquisition of Anagram. (Graphic: Business Wire)

Founded in 1998, Anagram delivers a full service CRO model to their customers including diagnostic imaging core lab (centralized quality control and central assessment of images in clinical trials) services. It is focused on cardiology, oncology, and neurology therapeutic areas. They conduct studies in the U.S., U.K., Spain, Netherlands, France, Germany, and more.

Anagram is a perfect fit for Avania, enabling the company to increase CRO business in Spain and providing greater access to a growing MedTech country. The addition will support cross-sell opportunity by adding scale and will eliminate reliance on current outsourcing partners. Avania customers will benefit from an expanded geographic footprint and an enhanced roster of subject matter experts concentrated on areas of key therapeutic expertise.

“The addition of Anagram furthers our vision of becoming a trusted global partner for the MedTech community, advancing innovations from bench to bedside and improving patient outcomes globally,” said Jason Monteleone, president and CEO of Avania. “It will provide us with a significant footprint in Spain and Southern Europe and further strengthen our cardiovascular and neurology franchises while expanding our oncology capabilities.”

About Avania

Avania is the leading global MedTech clinical research organization and advisory partner with a focus on medical devices, diagnostics/IVDs, and digital health. Core offerings include full service clinical research outsourcing, market access, reimbursement, regulatory, and product development advisory services. Avania’s vision is to be your trusted global partner in the evolution of your medical technology from innovation to commercialization to improving patient health and well-being. When you need to advance your medical technology, It Takes Avania.

About Anagram

Anagram is a Clinical Research Organization (CRO) based in Spain providing high quality services in clinical development and post-authorization trials for drugs and medical devices. Services include image central reading (core lab), analysis, and reporting by highly experienced professionals. Anagram has specialized expertise in cardiology, neurology, and oncology.

View source version on businesswire.com: https://www.businesswire.com/news/home/20241008530546/en/

Contacts

Holli Kroeker
+1 308 338 2358
pr@scorrmarketing.com

Jasmine Saba
+1 214 418 3201
jasmine.saba@avaniaclinical.com

About Business Wire

For more than 50 years, Business Wire has been the global leader in press release distribution and regulatory disclosure.

www.businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

Hero MotoSports Team Rally Starts Strong at Dakar Rally 20254.1.2025 15:11:00 EET | Press release

Hero MotoSports Team Rally, the motorsport team of the world's largest manufacturer of motorcycles and scooters, Hero MotoCorp, has kicked off its campaign at the 47th edition of the Dakar Rally. This is the ninth consecutive appearance of Hero MotoSports at the world’s toughest race. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250104745771/en/ Hero MotoSports team at Dakar Rally 2025 (Photo: Business Wire) Competing with a stellar line-up of three Rally GP class riders - Ross Branch, Sebastian Buhler, and Nacho Cornejo - the team started the rally on an optimistic note by finishing a short, yet challenging 29 km Prologue stage. Defending FIM World Champion Ross Branch stormed to an impressive second-place finish, setting the tone right for the team's campaign. His teammate Sebastian Bühler crossed the finish line clocking the 9th fastest time, while Nacho Cornejo finished at the 20th position – all three of them competin

Kinaxis Announces Board Transitions and Management Update2.1.2025 14:00:00 EET | Press release

Kinaxis® Inc. (“Kinaxis ” or the “Company ”) (TSX: KXS), a global leader in end-to-end supply chain orchestration, has, effective January 1, appointed Lynn Loewen to the Company’s Board of Directors and member of the Audit Committee. Due to current commitments, Betsy Rafael will not be seeking re-election to the Board at the 2025 annual general meeting. “I’m pleased to add an exceptionally qualified Director in Lynn, who will ensure we maintain the strength of the audit oversight function, while bolstering the Board in a number of ways,” said Robert (Bob) Courteau, chair and interim chief executive officer. “Betsy has been an exceptional board member and we fully respect that she has several other professional and personal commitments that are taking her time. We appreciate her significant efforts and contributions and wish her the very best.” Ms. Loewen is an accomplished business leader who has held several leadership positions, including at Bell Canada and Air Canada Jazz, as well a

Computershare Acquires CMi2i2.1.2025 13:09:00 EET | Press release

Computershare Limited (ASX: CPU) has announced that it has acquired CMi2i Limited. CMi2i provides independent and trusted advice to boards, executives and advisors of some of the largest public companies around the world. The company’s investor intelligence services, including its bondholder offering, help companies to identify and engage with investors on complex, contested and high stakes issues. It employs around 20 people in London and has a presence in New York, Milan and Madrid. Fiona Chalmers, CEO Issuer Services at Computershare said: “Bringing CMi2i into the Computershare Group is an exciting development that will enhance our investor relations offering to clients. “The acquisition further demonstrates our commitment to giving companies around the world the edge in the increasingly crucial area of shareholder engagement and ownership intelligence. “CMi2i’s approach to capital markets is very well respected, and their services and systems will complement our wider offering very

Aeromexico Named the Most On-Time Global Airline in 2024:2.1.2025 12:00:00 EET | Press release

Cirium, the world’s most trusted source of aviation analytics, today announced the winners of its 2024 On-Time Performance Review, celebrating airlines and airports that excelled in on-time and operational performance. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250101214982/en/ Cirium On-Time Performance Review 2024 (Photo: Business Wire) Cirium’s Annual report is the gold standard for global airline and airport performance analytics. An on-time flight is defined as a flight that arrives within 14:59 minutes of the scheduled gate arrival time. Airports measure punctuality as departing flights within 14:59 minutes of their scheduled departure time. Mexico’s Flag Carrier Tops Global Rankings Aeromexico claimed the prestigious title of the most On-Time “Global Airline” in 2024, achieving an impressive On-Time performance rate of 86.70%. Saudia followed closely as the runner-up with 86.35%, while Delta Air Lines secured thir

PQE Group Joins Project-COMFORT to Advance Patient-Centric Blood Collection and Diagnostics30.12.2024 08:50:00 EET | Press release

PQE Group, a global consulting firm specializing in Life Sciences, is proud to contribute its expertise as a strategic partner in the Project-COMFORT consortium. This innovative public-private partnership, funded by Horizon Europe and supported by the Innovative Health Initiative Joint Undertaking (IHI JU), officially launched in November 2024, marking a transformative shift in blood collection and diagnostics. The ambitious 42-month project brings together 51 organizations from a broad spectrum of sectors, including academia, research institutions, hospitals, foundations, SMEs, medical technology, and pharmaceutical companies, all united by the mission to simplify, reduce the invasiveness of, and increase accessibility to blood collection through cutting-edge, patient-centered microsampling technology. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20241229266268/en/ Follow Project-Comfort LinkedIn Page: https://www.linkedin.

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye